Project Details
Description
A Randomized Phase I/II Trial of Low Dose Anti-thymocyte Globulin (ATG) with Subsequent Adalimumab or Verapamil in New Onset Type 1 Diabetes (WAVE T1D)
| Status | Active |
|---|---|
| Effective start/end date | 11/25/25 → 1/31/31 |
Funding
- CITY OF HOPE
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.